Sign inJoin waitlistJoin the waitlist

Patricia A. Ganz

Director of Cancer Prevention and Control Research · Jonsson Comprehensive Cancer Center

Credentials: · · · ·

History

UCLA School of Public Health
1992–Present
UCLA School of Medicine
1978–Present

Research

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
JAMA · 2009 · 1,523 citations
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
New England Journal of Medicine · 2021 · 1,347 citations
Karnofsky performance status revisited: reliability, validity, and guidelines
Journal of Clinical Oncology · 1984 · Last of 3 authors · 1,222 citations

Susan Domchek
42 papers
Claudine Isaacs
40 papers
Olufunmilayo Olopade
40 papers
Judy Garber
39 papers
Michael Irwin
39 papers
Jeffrey Weitzel
37 papers
KO
Kenneth Offit
34 papers
Katherine Nathanson
33 papers
Nadine Tung
33 papers
Beth Karlan
31 papers
Katherine Kahn
31 papers
Mary Daly
31 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $1.3M · University of California Los Angeles
1996–2030
Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings
National Cancer Institute · R01
PI · $1.7M · University of California Los Angeles
2024–2029
Cognitive Training for Cancer-Related Cognitive Impairment: A Multi-Center Randomized Controlled Trial
National Cancer Institute · R01
PI · $2.2M · Ohio State University
2023–2028
Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials
National Cancer Institute · U01
PI · $3.7M · Cedars-Sinai Medical Center
2018–2025

Clinical trials

Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
2021–2024
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment
Principal investigator · Terminated
Blue Note Therapeutics
2021–2022
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer
Principal investigator · Terminated
Jonsson Comprehensive Cancer Center
2021–2023
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)
Principal investigator · Unknown
Jonsson Comprehensive Cancer Center
2017–2024